The EU Biotech Act: Europe’s ambition for biotechnology
14 April @ 2:30 pm – 3:30 pm Online
Join Director General Sandra Gallina and EuropaBio to explore the EU Biotech Act proposal, published in December 2025.
The webinar explores the Goal of the Act, to boost innovation, support development of biotech products and accelerate time-to-market, making use of industrial enablers and regulatory simplification.
This webinar will introduce the drivers behind the Biotech Act proposal plus its diverse and ambitious mechanisms to boost EU biotech delivery. It will discuss how mechanisms might work and the interlink of the Act with the wider European Legislative landscape, and its legislative pathway into action for the EU.
Webinar delegates will have the opportunity to ask Director General Gallina questions during the event and EuropaBio will publish a summary for all participants.
AGENDA
14h30: Introduction – Dr Claire Skentelbery, Director General EuropaBio
14h40: The Biotech Act in focus – Director General Sandra Gallina, DG Health and Food Safety, European Commission:
- Regulatory streamlining and facilitation in health, food and other biotech
- Industrial enablers including High Impact Strategic Projects, Boosting innovative biotech & biosimilars, Access to Finance, AI and Data, Biosecurity & Defence
15h10: Discussion and audience Q&A
15h30: Close
Who should attend? If you are active within biotechnology in any sector, you should attend to understand what the Act means for you, how you should be involved and what happens next.
Register below